Batavia Biosciences Inc.

Woburn, MA

UEI
ZZEEPVLGD5M9
CAGE
76TZ2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
300 Tradecenter Drive #6650, Woburn, MA 01801, USA
Founded
2010
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
51 Wholesale Trade – Nondurable Goods
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract subawards

Prime contractor Prime award Amount Awarded
International Aids Vaccine Initiative Inc. THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV)… 75A50121C00077 $44,568
International Aids Vaccine Initiative Inc. THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV)… 75A50121C00077 $113,027
International Aids Vaccine Initiative Inc. THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV)… 75A50121C00077 $36,813
International Aids Vaccine Initiative Inc. THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV)… 75A50121C00077 $257,929
International Aids Vaccine Initiative Inc. THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV)… 75A50121C00077 $431,818

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Batavia Biosciences Inc. is a science-based CDMO that offers personalized services supporting all stages of biopharmaceutical development, from cloning to GMP manufacturing and release of clinical material for phase I/II studies. As a foreign owned, for-profit corporation registered in SAM.gov, Batavia Biosciences has received multiple federal subcontract awards to provide biopharmaceutical products and services.

Specific federal subcontracts received by Batavia Biosciences include manufacturing services for viral vectors such as VSV and RVSV constructs containing genes from pathogens like Ebola, Marburg virus, and SARS-CoV-2. These viral vectors were developed as vaccine candidates. Batavia's subcontracts were awarded by the International AIDS Vaccine Initiative to provide process improvement, scalable manufacturing, cGMP production, and storage solutions for these vectors. The nature of work performed under these subcontracts includes cloning, viral seed generation, process optimization, engineering runs, cGMP manufacturing, and storage of vaccine candidates for early phase clinical trials.

SBA capabilities narrative

Batavia is an expert in Biologics process development. We have our proprietary STEP R Technology that improves the production of difficult to express proteins. Stable cell line generation. Upstream process development. Downstream process development. Biosimilar.

Quick answers

Is Batavia Biosciences Inc. registered in SAM.gov?

Yes. Batavia Biosciences Inc.'s SAM.gov registration is active through April 6, 2027.

On GovTribe

See Batavia Biosciences Inc.'s full federal record

  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors